Your browser doesn't support javascript.
loading
Launching a saliva-based SARS-CoV-2 surveillance testing program on a university campus
Alexander J. Ehrenberg; Erica A. Moehle; Cara E. Brook; Andrew H. Doudna Cate; Lea B. Witkowsky; Rohan Sachdeva; Ariana Hirsh; Kerrie Barry; Jennifer R. Hamilton; Enrique Lin-Shiao; Shana McDevitt; Luis Valentin-Alvarado; Kaitlyn N. Letourneau; Lauren Hunter; Amanda Keller; Kathleen Pestal; Phillip A. Frankino; Andrew Murley; Divya Nandakumar; Elizabeth C. Stahl; Connor Tsuchida; Holly K. Gildea; Andrew G. Murdock; Megan L. Hochstrasser; Elizabeth O'Brien; Alison Ciling; Alexandra Tsitsiklis; Kurtresha Worden; Claire Dugast-Darzacq; Stephanie G. Hays; Colin C. Barber; Riley McGarrigle; Emily Lam; David Ensminger; Lucie Bardet; Carolyn Sherry; - IGI SARS-CoV-2 Testing Consortium; Anna Harte; Guy Nicolette; Petros Giannikopoulos; Dirk Hockemeyer; Maya Petersen; Fyodor D. Urnov; Bradley R. Ringeisen; Mike Boots; Jennifer A. Doudna.
Afiliação
  • Alexander J. Ehrenberg; University of California, Berkeley; Innovative Genomics Institute
  • Erica A. Moehle; University of California, Berkeley; Innovative Genomics Institute
  • Cara E. Brook; University of California, Berkeley; Innovative Genomics Institute
  • Andrew H. Doudna Cate; University of California, Berkeley
  • Lea B. Witkowsky; University of California, Berkeley; Innovative Genomics Institute
  • Rohan Sachdeva; University of California, Berkeley; Innovative Genomics Institute
  • Ariana Hirsh; University of California, Berkeley; Innovative Genomics Institute
  • Kerrie Barry; Lawrence Berkeley National Laboratory
  • Jennifer R. Hamilton; University of California, Berkeley; Innovative Genomics Institute
  • Enrique Lin-Shiao; University of California, Berkeley; Innovative Genomics Institute
  • Shana McDevitt; University of California, Berkeley; Innovative Genomics Institute
  • Luis Valentin-Alvarado; University of California, Berkeley; Innovative Genomics Institute
  • Kaitlyn N. Letourneau; University of California, Berkeley
  • Lauren Hunter; University of California, Berkeley
  • Amanda Keller; Innovative Genomics Institute
  • Kathleen Pestal; University of California, Berkeley; Innovative Genomics Institute
  • Phillip A. Frankino; University of California, Berkeley
  • Andrew Murley; University of California, Berkeley
  • Divya Nandakumar; University of California, Berkeley; Innovative Genomics Institute
  • Elizabeth C. Stahl; University of California, Berkeley; Innovative Genomics Institute
  • Connor Tsuchida; University of California, Berkeley; Innovative Genomics Institute
  • Holly K. Gildea; University of California, Berkeley
  • Andrew G. Murdock; University of California, Berkeley; Innovative Genomics Institute
  • Megan L. Hochstrasser; Innovative Genomics Institute
  • Elizabeth O'Brien; University of California, Berkeley; Innovative Genomics Institute
  • Alison Ciling; University of California, Berkeley; Innovative Genomics Institute
  • Alexandra Tsitsiklis; University of California, Berkeley
  • Kurtresha Worden; University of California, Berkeley; Innovative Genomics Institute
  • Claire Dugast-Darzacq; University of California, Berkeley
  • Stephanie G. Hays; University of California, Berkeley
  • Colin C. Barber; University of California, Berkeley
  • Riley McGarrigle; University of California, Berkeley; Innovative Genomics Institute
  • Emily Lam; University of California, Berkeley
  • David Ensminger; University of California, Berkeley
  • Lucie Bardet; Innovative Genomics Institute
  • Carolyn Sherry; Innovative Genomics Institute
  • - IGI SARS-CoV-2 Testing Consortium;
  • Anna Harte; University of California, Berkeley; University Health Services, UC Berkeley
  • Guy Nicolette; University of California, Berkeley; University Health Services, UC Berkeley
  • Petros Giannikopoulos; Innovative Genomics Institute
  • Dirk Hockemeyer; University of California, Berkeley; Innovative Genomics Institute; Chan Zuckerberg Biohub
  • Maya Petersen; University of California, Berkeley
  • Fyodor D. Urnov; University of California, Berkeley; Innovative Genomics Institute
  • Bradley R. Ringeisen; University of California, Berkeley; Innovative Genomics Institute
  • Mike Boots; University of California, Berkeley
  • Jennifer A. Doudna; University of California, Berkeley; Innovative Genomics Institute; Howard Hughes Medical Institute
Preprint em Inglês | medRxiv | ID: ppmedrxiv-21250385
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
Regular surveillance testing of asymptomatic individuals for SARS-CoV-2 has played a vital role in SARS-CoV-2 outbreak prevention on college and university campuses. Here we describe the voluntary saliva testing program instituted at the University of California, Berkeley during an early period of the SARS-CoV-2 pandemic in 2020. The program was administered as a research study ahead of clinical implementation, enabling us to launch surveillance testing while continuing to optimize the assay. Results of both the testing protocol itself and the study participants experience show how the program succeeded in providing routine, robust testing capable of contributing to outbreak prevention within a campus community and offer strategies for encouraging participation and a sense of civic responsibility.
Licença
cc_by_nd
Texto completo
Adicionar na Minha BVS
Imprimir
XML
Buscar no Google
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo
Adicionar na Minha BVS
Imprimir
XML
Buscar no Google
Texto completo: Disponível Coleções: Preprints Base de dados: medRxiv Tipo de estudo: Estudo prognóstico Idioma: Inglês Ano de publicação: 2021 Tipo de documento: Preprint